Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.

Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time. J Clin Oncol. 2008 Apr 20; 26(12):1919-21.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.